Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery

This study has been completed.
Sponsor:
Collaborators:
Astellas Pharma US, Inc.
Cardiome Pharma
Information provided by:
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00125320
First received: July 28, 2005
Last updated: December 19, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
No publications provided by Astellas Pharma Inc

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):